Vivos Therapeutics, Inc. (VVOS)
Market Open
11 Sep, 15:17
NASDAQ (CM) NASDAQ (CM) Primary $
0. 18
-0
-0.3304%
$
2.5M Market Cap
- P/E Ratio
- Div Yield
616,363 Volume
-3.4 Eps
$ 0.18
Previous Close 
Want to track VVOS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vivos Therapeutics, Inc. (VVOS) Statistics
Valuation metrics
Market Cap 2.5M
Enterprise value 12.95M
Trailing P/E (ttm) -0.09
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 0.12
Price/Book (mrq) -0.86
Enterprise Value/Revenue 0.62
Enterprise Value/EBITDA -0.56
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.46M
Average volume (90 days) 1.54M
Price summary
52-Week low 0.16
52-Week high 3.7
Beta -
50-Day moving average 0.26
200-Day moving average 1.04
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 27 Oct 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.22%
Operating margin -1.08%
Operational effectiveness
Return on assets -1.06%
Return on equity 26.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.18
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.45
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.1
Total debt (mrq) -
Total Debt/Equity (mrq) -3.18
Current ratio (mrq) 0.21%
Book value per share (mrq) -0.23
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
